She
youngPatients
screeningBehavior
excision
filipinoWomen
novelTargetedTherapeuticOptions
results
BACKGROUND
CXCR4
18f-fdgPet/ctImages
hormonalContraceptionUse
intake
longScanTime
patients
tumorDetectability
components
theirEmergingRole
we
contrastAgents
cohortStudy
agreement
third-degree
smallMoleculeInhibitors
95PercecntConfidenceIntervals
theResulting
Metastases
lungCancer
Anthracyclines
12-15Percecnt
Aims
amount
analysis
osteopontin-750Accumulation
cxcr4-targetedPetImaging
cancer
unenhancedMriTechniques
osteopontin-basedProbe
healthcarePolicyMakers
seromaFormation
article
betterUnderstanding
ctnLevels
relationship
moreSpecificApplications
homologousRecombinationPathway
signature
dose-dependentReduction
coxProportionalHazardRegressionModels
cancerRiskPerception
Patients
initialResults
doses
466Percecnt
ourFindings
breastCancerDiagnosis
probe
Information
lungCancer
tumor-to-backgroundRatios
theirAbility
radicalSurgicalApproaches
differentialDiagnosis
percecntConfidenceIntervals
recentDanishCohortStudy
imagingTechnique
medianAmount
24ApplicableCases
breastImagingModality
tenStudies
manyFeatures
They
lowCtnLevels
evaluation
importantCornerstone
summaryHazardRatios
comprehensiveSearch
highIndex
significantAdvances
surgicalExcision
women
she
Ulceration
similarTowaveletFilter
they
We
increase
forty-threeCases
postmenopausalPatient
brd4Regulation
disease
IORT
biomarker
membraneTypeMr
understanding
treatment
discovery
percecnt
options
multiresolutionResult
Mammography
contraceptionUse
locoregionalRadiotherapy
role
acromegaly
RESULTS
radiotherapy
membraneTypeMannoseReceptor
identification
novelPowerfulTechnique
collectedSignatures
cornerstone
observationalStudies
troponins
colorectalCancer
mutations
MRI
seromaProduction
differentStudies
femalePatients
strongAssociation
five
case
lesion
12SampledWomen
furtherDevelopment
studies
neuroma
I2
it
breastCancer
[]anti-her2Therapies
herPresentation
People
directRelationship
screeningTools
Comparison
anti-her2Therapy
Efforts
cardiacTroponins
breastCancer
medianFollow-up
herDisease
mammographicImages
association
alternativeContrast-enhancedScreeningTools
theirInhibition
medianAge
study
time
diagnosticPerformance
research
mriTechniques
aim
the
breastCancer
familialCancerClustering
most
24Cases
subcutaneousBreastTumor
anti-her2Therapies
necessity
decreases
improvedDetection
currentDevelopments
diagnosticEvaluation
strongContrast
fluorescenceImagingExVivo
markedReduction
ourLiteratureReview
respondents
patient
standardizedImagingProtocol
risk
barcodeMode
traumaticNeuroma
numerousGene-expression-basedPrognosticSignatures
clinicians
traumaticBreastNeuromas
follow-up
signatures
subtype-specificSignature
msotImaging
breastNeuromas
higher
features
theirCardiotoxicities
mriProtocols
development
availableContrastAgents
improvedBreastCancerOs
cases
1
detection
coxHazardRegressionModels
repair
selectiveBinding
use
signalIntensity
subjectiveRisk
binding
involved
conventionalX-rayMammography
brd4PharmacologicalInhibition
higherSuvmax
petImaging
Breast
adjustment
furtherResearch
breast
AION
detectionofBreastCancer
brcanessPhenotype
Transcripts
higherResolution
age
patientDemographics
prolongedRecovery
experiences
segmentationAlgorithm
metastaticDisease
brd4Inhibition
cTn
pharmacologicalInduction
conservativeTreatment
observedVariation
clinicalBreastExamination
TNBC